Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP.

scientific article published on August 1997

Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1031494162
P356DOI10.1038/NG0897-402
P698PubMed publication ID9241282

P2093author name stringBird TD
Tapscott SJ
Klesert TR
Otten AD
P2860cites workStructure, function and expression of a murine homeobox protein AREC3, a homologue of Drosophila sine oculis gene product, and implication in developmentQ24545877
Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the geneQ28285882
Identification and expression of six family genes in mouse retinaQ28506421
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.Q33968674
Enhancers increase the probability but not the level of gene expressionQ34105301
Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structureQ34226936
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.Q34290920
Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophyQ34348155
An unstable triplet repeat in a gene related to myotonic muscular dystrophyQ34355359
Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy.Q34363062
A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeatQ34374463
Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determinationQ36505898
Myotonic dystrophy: will the real gene please step forward!Q41170292
Use of retroviral vectors for gene transfer and expressionQ41582824
Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.Q52200997
Normal levels of DM RNA and myotonin protein kinase in skeletal muscle from adult myotonic dystrophy (DM) patients.Q52523367
Effect of Myotonic Dystrophy Trinucleotide Repeat Expansion on DMPK Transcription and ProcessingQ62661555
Nucleosome assembly on CTG triplet repeatsQ71143510
Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathyQ71167717
Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy geneQ72073093
Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal alleleQ72096934
Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elementsQ72333265
Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM geneQ72896182
Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesisQ72957468
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectmyotonic dystrophyQ1860507
P304page(s)402-406
P577publication date1997-08-01
P1433published inNature GeneticsQ976454
P1476titleTrinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP.
P478volume16

Reverse relations

cites work (P2860)
Q40971215(CTG)n repeats markedly inhibit differentiation of the C2C12 myoblast cell line: implications for congenital myotonic dystrophy
Q47194897250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.
Q44925270Aberrant Myokine Signaling in Congenital Myotonic Dystrophy
Q54982478Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.
Q38330480Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.
Q35943348Altered replication in human cells promotes DMPK (CTG)(n) · (CAG)(n) repeat instability
Q36848720Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.
Q39012706Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat.
Q26801165Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)
Q36594935CAG/CTG repeats alter the affinity for the histone core and the positioning of DNA in the nucleosome
Q48854625CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.
Q40789249CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus
Q38663998Characterization of a canine tetranucleotide microsatellite marker located in the first intron of the tumor necrosis factor alpha gene
Q52547985Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene.
Q40553411Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat
Q34096504Clinical and genetic heterogeneity in myotonic dystrophies
Q24650948Comparative genomics and molecular dynamics of DNA repeats in eukaryotes
Q24554423Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya
Q48726587Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy
Q38713995CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy
Q30855205Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features
Q47072189D-six4 plays a key role in patterning cell identities deriving from the Drosophila mesoderm.
Q33842956DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model
Q59071144DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing
Q74579021Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy
Q74609017Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts
Q47154610Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy.
Q35807015Distribution and characterization of regulatory elements in the human genome
Q41643458Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice
Q36939612Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline
Q34252137Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation
Q34699401Dominantly inherited, non-coding microsatellite expansion disorders
Q92096984Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1
Q47070964Drosophila homolog of the myotonic dystrophy-associated gene, SIX5, is required for muscle and gonad development.
Q37695480Epigenetic changes and non-coding expanded repeats
Q35210734Epigenetic mechanisms and genome stability.
Q26770705Epigenetics and Triplet-Repeat Neurological Diseases
Q77058046Evolution of simple repeats in DNA and their relation to human disease
Q34399378Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues
Q27301037Expanded GAA repeats impair FXN gene expression and reposition the FXN locus to the nuclear lamina in single cells
Q39584664Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation
Q28589912Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site
Q52173012Expression of the myotonic dystrophy locus-associated homeodomain protein in congenital myotonic dystrophy.
Q74607477Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes
Q24516571Functional analysis of the homeodomain protein SIX5.
Q28585557Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
Q39408417Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion
Q48726618Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients
Q24555640In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts
Q47933637Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole
Q33804446Inherited skeletal muscle disorders
Q24301335Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing
Q34466715Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
Q34142085Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
Q93601664Medical genetics: advances in brief
Q55560133Medical genetics: advances in brief: Frataxin gene of Friedreich's ataxia is targeted to mitochondria.
Q54967735Medical genetics: advances in brief: Relationship between lifetime ovulatory cycles and over-expression of mutant P53 in epithelial ovarian cancer.
Q28504484Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy
Q36640173Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
Q27687330Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.
Q26798784Muscle wasting in myotonic dystrophies: a model of premature aging
Q39533050Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy
Q33548657Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy
Q88453318Myotonic Dystrophy and Developmental Regulation of RNA Processing
Q37434343Myotonic dystrophy mouse models: towards rational therapy development.
Q73408342Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells
Q41499535Myotonic dystrophy type 1 presenting as male infertility
Q39043041Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
Q34446614Myotonic dystrophy--a multigene disorder.
Q35738537Myotonic dystrophy: RNA pathogenesis comes into focus
Q34658838Myotonic dystrophy: molecular windows on a complex etiology
Q28287940New 5'-(CGG)n-3' repeats in the human genome
Q92740840New myotonic dystrophy type 1 mouse model
Q33933843Nuclear proteins and cell death in inherited neuromuscular disease
Q41075540Overexpression of 3'-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblast differentiation in vitro
Q37724514Partners in crime: bidirectional transcription in unstable microsatellite disease
Q37216891RNA-mediated toxicity in neurodegenerative disease
Q24290177Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy
Q48168210Reduction of the DM-associated homeo domain protein (DMAHP) mRNA in different brain areas of myotonic dystrophy patients.
Q41051948Ribozyme-mediated trans-splicing of a trinucleotide repeat.
Q28219080Six and Eya expression during human somitogenesis and MyoD gene family activation
Q30531281Six4, a putative myogenin gene regulator, is not essential for mouse embryonal development.
Q28505273Skeletal muscle Na currents in mice heterozygous for Six5 deficiency
Q47747960Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity
Q22253935Structure, mapping and expression of the human gene encoding the homeodomain protein, SIX2
Q33903996The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?
Q48310101The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients
Q41968306The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat
Q35226294The floppy infant: contribution of genetic and metabolic disorders
Q37341015The six family of homeobox genes in development and cancer
Q57113916Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9
Q37448481Transcriptionally Repressive Chromatin Remodelling and CpG Methylation in the Presence of Expanded CTG-Repeats at the DM1 Locus
Q34267388Transgenic mouse models for myotonic dystrophy type 1 (DM1)
Q33936621Triplet repeat expansion in neuromuscular disease
Q34446513Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis
Q47069426UNC-39, the C. elegans homolog of the human myotonic dystrophy-associated homeodomain protein Six5, regulates cell motility and differentiation
Q36201577Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells
Q24548860Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein

Search more.